What is Zacks Research’s Estimate for Palomar Q2 Earnings?

Palomar Holdings, Inc. (NASDAQ:PLMR) – Zacks Research boosted their Q2 2026 earnings per share estimates for Palomar in a research note issued on Friday, June 19th. Zacks Research analyst Team now expects that the company will post earnings of $1.59 per share for the quarter, up from their prior forecast of $1.58. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Palomar’s current full-year earnings is $8.99 per share. Zacks Research also issued estimates for Palomar’s Q3 2026 earnings at $2.63 EPS, FY2026 earnings at $9.87 EPS, Q2 2027 earnings at $2.03 EPS, FY2027 earnings at $9.83 EPS and Q1 2028 earnings at $3.00 EPS.

A number of other research firms also recently issued reports on PLMR. Piper Sandler decreased their target price on shares of Palomar from $151.00 to $132.00 and set an “overweight” rating for the company in a research report on Monday, May 11th. Weiss Ratings raised Palomar from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, June 18th. JPMorgan Chase & Co. decreased their price objective on Palomar from $160.00 to $150.00 and set an “overweight” rating for the company in a report on Tuesday, May 26th. Wall Street Zen downgraded Palomar from a “buy” rating to a “hold” rating in a research note on Sunday, March 1st. Finally, Keefe, Bruyette & Woods dropped their target price on Palomar from $186.00 to $159.00 and set an “outperform” rating on the stock in a report on Wednesday, May 13th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $147.75.

Palomar Stock Up 4.0%

NASDAQ:PLMR opened at $116.08 on Wednesday. The firm has a market capitalization of $3.08 billion, a P/E ratio of 16.17 and a beta of 0.44. Palomar has a 1-year low of $100.81 and a 1-year high of $162.65. The company’s fifty day moving average price is $115.98 and its 200-day moving average price is $122.37. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.49 and a quick ratio of 0.49.

Palomar (NASDAQ:PLMR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.17 by $0.14. Palomar had a net margin of 20.11% and a return on equity of 22.62%. The company had revenue of $278.94 million during the quarter, compared to analyst estimates of $557.79 million. During the same period last year, the firm posted $1.87 EPS. Palomar’s revenue for the quarter was up 59.7% compared to the same quarter last year.

Hedge Funds Weigh In On Palomar

A number of large investors have recently bought and sold shares of the business. Summit Global Investments grew its holdings in Palomar by 1.7% in the 4th quarter. Summit Global Investments now owns 4,646 shares of the company’s stock worth $626,000 after buying an additional 79 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in Palomar by 3.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 2,546 shares of the company’s stock valued at $333,000 after acquiring an additional 82 shares in the last quarter. Quadrant Capital Group LLC boosted its position in Palomar by 2.0% during the 4th quarter. Quadrant Capital Group LLC now owns 4,464 shares of the company’s stock worth $602,000 after acquiring an additional 88 shares during the period. Clearstead Advisors LLC boosted its position in Palomar by 31.0% during the 3rd quarter. Clearstead Advisors LLC now owns 397 shares of the company’s stock worth $46,000 after acquiring an additional 94 shares during the period. Finally, California State Teachers Retirement System grew its stake in shares of Palomar by 0.4% in the second quarter. California State Teachers Retirement System now owns 24,207 shares of the company’s stock worth $3,734,000 after purchasing an additional 97 shares in the last quarter. Institutional investors and hedge funds own 90.25% of the company’s stock.

Insiders Place Their Bets

In other news, President Jon Christianson sold 3,000 shares of the stock in a transaction dated Tuesday, April 7th. The shares were sold at an average price of $125.00, for a total transaction of $375,000.00. Following the sale, the president directly owned 62,919 shares of the company’s stock, valued at $7,864,875. This represents a 4.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mac Armstrong sold 3,500 shares of the firm’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $114.39, for a total value of $400,365.00. Following the sale, the chief executive officer owned 332,888 shares in the company, valued at $38,079,058.32. This trade represents a 1.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 15,134 shares of company stock valued at $1,896,081 in the last ninety days. 3.70% of the stock is owned by corporate insiders.

Key Stories Impacting Palomar

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Zacks Research raised Palomar’s FY2026 EPS estimate to $9.87 from $8.99, signaling improved expected profitability.
• Positive Sentiment: The firm also nudged up Q2 2026 EPS to $1.59 and Q2 2027 EPS to $2.03, suggesting modestly better near-term earnings outlook.
• Positive Sentiment: A Zacks article included Palomar among P&C insurers expected to stay resilient during the 2026 hurricane season, which may reinforce confidence in the company’s risk profile. Article title
• Neutral Sentiment: Zacks Research maintained a Hold rating, indicating no major change in overall stance despite the estimate revisions.
• Neutral Sentiment: Some longer-dated estimates were only slightly changed, including a small Q4 2026 increase and a modest Q1 2028 reduction, which likely won’t move the stock much on their own.
• Negative Sentiment: Zacks trimmed its Q3 2026 EPS estimate to $2.63 from $2.84, and also lowered FY2027 and FY2028 forecasts, which could temper enthusiasm for Palomar’s longer-term earnings trajectory.

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.